{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T19:41:24Z","timestamp":1790106084916,"version":"4.0.1"},"reference-count":53,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vascular Pharmacology"],"published-print":{"date-parts":[[2019,9]]},"DOI":"10.1016\/j.vph.2019.106564","type":"journal-article","created":{"date-parts":[[2019,6,7]],"date-time":"2019-06-07T11:39:55Z","timestamp":1559907595000},"page":"106564","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"special_numbering":"C","title":["Vitamin D levels and platelet reactivity in diabetic patients receiving dual antiplatelet therapy"],"prefix":"10.1016","volume":"120","author":[{"given":"Monica","family":"Verdoia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrizia","family":"Pergolini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matteo","family":"Nardin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberta","family":"Rolla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federica","family":"Negro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elvin","family":"Kedhi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harry","family":"Suryapranata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Marcolongo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Carriero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"De Luca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.vph.2019.106564_bb0005","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1093\/eurheartj\/ehx419","volume":"39","author":"Valgimigli","year":"2018","journal-title":"Eur. Heart J."},{"issue":"5","key":"10.1016\/j.vph.2019.106564_bb0010","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/j.pcad.2007.11.004","article-title":"Reperfusion strategies in acute ST-elevation myocardial infarction: an overview of current status","volume":"50","author":"De Luca","year":"2008","journal-title":"Prog. Cardiovasc. Dis."},{"issue":"4","key":"10.1016\/j.vph.2019.106564_bb0015","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1097\/FJC.0000000000000052","article-title":"Benefits from new ADP antagonists as compared with clopidogrel in patients with stable angina or acute coronary syndrome undergoing invasive management: a meta-analysis of randomized trials","volume":"63","author":"Verdoia","year":"2014","journal-title":"J. Cardiovasc. Pharmacol."},{"issue":"5","key":"10.1016\/j.vph.2019.106564_bb0020","doi-asserted-by":"crossref","first-page":"594","DOI":"10.2174\/1570161113666141229115302","article-title":"Recent advances in optimal adjunctive antithrombotic therapy in STEMI patients undergoing primary angioplasty: an overview","volume":"13","author":"De Luca","year":"2015","journal-title":"Curr. Vasc. Pharmacol."},{"issue":"16","key":"10.1016\/j.vph.2019.106564_bb0025","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.1161\/CIRCULATIONAHA.108.791061","volume":"118","author":"Wiviott","year":"2008","journal-title":"Circulation."},{"key":"10.1016\/j.vph.2019.106564_bb0030","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1056\/NEJMoa0904327","article-title":"Cannon CP, Emanuelsson H, held C, Horrow J, Husted S, James S, Katus H, Mahaffey KW, Scirica BM, Skene a, Steg PG, storey RF, Harrington RA; PLATO investigators, Freij a, Thors\u00e9n M. Ticagrelor versus clopidogrel in patients with acute coronary syndromes","volume":"361","author":"Wallentin","year":"2009","journal-title":"N. Engl. J. Med."},{"issue":"24","key":"10.1016\/j.vph.2019.106564_bb0035","doi-asserted-by":"crossref","first-page":"2261","DOI":"10.1016\/j.jacc.2013.07.101","article-title":"Gurbel PA; working group on on-treatment PlateletReactivity. Consensus and update on the definition of on-treatment platelet reactivity to adenosine diphosphate associated with ischemia and bleeding","volume":"62","author":"Tantry","year":"2013","journal-title":"J. Am. Coll. Cardiol."},{"issue":"9892","key":"10.1016\/j.vph.2019.106564_bb0040","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1016\/S0140-6736(13)61170-8","article-title":"Platelet reactivity and clinical outcomes after coronary artery implantation of drug-eluting stents (ADAPT-DES): a prospective multicentre registry study","volume":"382","author":"Stone","year":"2013","journal-title":"Lancet."},{"issue":"9","key":"10.1016\/j.vph.2019.106564_bb0045","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1016\/j.amjcard.2015.02.012","article-title":"Bal ditSollier C, Drouet L, Henry P. predictors of high on-aspirin platelet reactivity in high-risk vascular patients treated with single or dual antiplatelet therapy","volume":"115","author":"Amsallem","year":"2015","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.vph.2019.106564_bb0050","doi-asserted-by":"crossref","first-page":"b566","DOI":"10.1136\/bmj.b5664","article-title":"Diagnosis and management of vitamin D deficiency","volume":"340","author":"Pearce","year":"2010","journal-title":"BMJ"},{"issue":"7","key":"10.1016\/j.vph.2019.106564_bb0055","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1111\/eci.12281","article-title":"Vitamin D deficiency is independently associated with the extent of coronary artery disease","volume":"44","author":"Verdoia","year":"2014","journal-title":"Eur. J. Clin. Invest."},{"key":"10.1016\/j.vph.2019.106564_bb0060","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1001\/archinte.168.11.1174","article-title":"25-hydroxyvitamin D and risk of myocardial infarction in men: a prospective study","volume":"168","author":"Giovannucci","year":"2008","journal-title":"Arch. Intern. Med."},{"issue":"19","key":"10.1016\/j.vph.2019.106564_bb0065","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000000857","article-title":"Vitamin D plasma levels and in-hospital and 1-year outcomes in acute coronarysyndromes: a prospectivestudy","volume":"94","author":"De Metrio","year":"2015","journal-title":"Medicine (Baltimore)"},{"issue":"4","key":"10.1016\/j.vph.2019.106564_bb0070","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1177\/1479164110383994","article-title":"Platelet abnormalities in diabetes mellitus","volume":"7","author":"Ferreiro","year":"2010","journal-title":"Diab. Vasc. Dis. Res."},{"issue":"5","key":"10.1016\/j.vph.2019.106564_bb0075","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/j.numecd.2010.08.005","article-title":"Uric acid does not affect the prevalence and extent of coronary artery disease. results from a prospective study","volume":"22","author":"De Luca","year":"2012","journal-title":"Nutr. Metab. Cardiovasc. Dis."},{"key":"10.1016\/j.vph.2019.106564_bb0080","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1056\/NEJMra070553","article-title":"Vitamin D deficiency","volume":"357","author":"Holick","year":"2007","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.vph.2019.106564_bb0085","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1097\/MBC.0b013e32835d546e","article-title":"PlA(1)\/PlA(2) polymorphism does not influence response to Gp IIb-IIIa inhibitors in patients undergoing coronary angioplasty","volume":"24","author":"Verdoia","year":"2013","journal-title":"Blood Coagul. Fibrinolysis"},{"key":"10.1016\/j.vph.2019.106564_bb0090","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1111\/j.1751-553X.2012.01428.x","article-title":"Role of the laboratory in monitoring patientsreceiving dual antiplatelet therapy","volume":"34","author":"Vidali","year":"2012","journal-title":"Int. J. Lab. Hematol."},{"key":"10.1016\/j.vph.2019.106564_bb0095","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1016\/j.jacc.2010.04.047","article-title":"Working group on high on-treatment platelet reactivity. consensus and future directions on the definition of high on-treatment platelet reactivity to adenosine diphosphate","volume":"56","author":"Bonello","year":"2010","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.vph.2019.106564_bb0100","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.atherosclerosis.2009.03.042","article-title":"Diabetes mellitus is associated with distal embolization, impaired myocardial perfusion, and higher mortality in patients with ST-segment elevation myocardial infarction treated with primary angioplasty and glycoprotein IIb-IIIa inhibitors","volume":"207","author":"De Luca","year":"2009","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.vph.2019.106564_bb0105","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.numecd.2013.11.002","article-title":"Meta-analysis of 14 trials comparing bypass grafting vs drug-eluting stents in diabetic patients with multivessel coronary artery disease","volume":"24","author":"De Luca","year":"2014","journal-title":"Nutr. Metab. Cardiovasc. Dis."},{"issue":"11","key":"10.1016\/j.vph.2019.106564_bb0110","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1016\/j.amjcard.2005.01.088","article-title":"Zwolle myocardial infarction study group. Comparison of myocardial perfusion after successful primary percutaneous coronary intervention in patients with ST-elevation myocardial infarction with versus without diabetes mellitus","volume":"95","author":"Timmer","year":"2005","journal-title":"Am. J. Cardiol."},{"issue":"2","key":"10.1016\/j.vph.2019.106564_bb0115","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/j.atherosclerosis.2009.12.012","article-title":"STEMI 2003 registry collaborators. impact of diabetes on survival in patients with ST-segment elevation myocardial infarction treated by primary angioplasty: insights from the POLISH STEMI registry","volume":"210","author":"De Luca","year":"2010","journal-title":"Atherosclerosis"},{"issue":"4","key":"10.1016\/j.vph.2019.106564_bb0120","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1097\/MCA.0000000000000601","article-title":"The paradox of clopidogrel use in patients with acute coronary syndromes and diabetes: insight from the Diabetes and Acute Coronary Syndrome Registry","volume":"29","author":"Ferlini","year":"2018","journal-title":"Coron. Artery Dis."},{"issue":"4","key":"10.1016\/j.vph.2019.106564_bb0125","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.2337\/dc12-1507","article-title":"Diaz de la Llera LS, Pasceri V, Di Lorenzo E, Violini R, Suryapranata H, Stone GW; DESERT cooperation.Impact of diabetes on long-term outcome after primary angioplasty: insights from the DESERT cooperation","volume":"36","author":"De Luca","year":"2013","journal-title":"Diabetes Care"},{"issue":"9281","key":"10.1016\/j.vph.2019.106564_bb0130","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/S0140-6736(01)05701-4","article-title":"Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study","volume":"358","author":"Mehta","year":"2001","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.vph.2019.106564_bb0135","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3810\/hp.2014.10.1139","article-title":"Point-of-care platelet reactivity determination with VerifyNow-P2Y12 following administration of clopidogrel or prasugrel: data from a real-world, clinical care inpatient setting","volume":"42","author":"Bae","year":"2014","journal-title":"Hosp. Pract."},{"issue":"8","key":"10.1016\/j.vph.2019.106564_bb0140","doi-asserted-by":"crossref","first-page":"2430","DOI":"10.2337\/diabetes.54.8.2430","article-title":"Platelet function profiles in patients with type 2 diabetes and coronary artery disease on combined aspirin and clopidogrel treatment","volume":"54","author":"Angiolillo","year":"2005","journal-title":"Diabetes."},{"issue":"7","key":"10.1016\/j.vph.2019.106564_bb0145","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1093\/eurheartj\/ehq494","article-title":"A pharmacodynamic comparison of prasugrel vs. high-dose clopidogrel in patients with type 2 diabetes mellitus and coronary artery disease: results of the optimizing anti-platelet therapy IndiabetesMellitUS (OPTIMUS)-3 trial","volume":"32","author":"Angiolillo","year":"2011","journal-title":"Eur. Heart J."},{"issue":"11","key":"10.1016\/j.vph.2019.106564_bb0150","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1161\/CIRCULATIONAHA.116.023402","article-title":"Pharmacodynamic comparison of prasugrel versus Ticagrelor in patients with type 2 diabetes mellitus and coronary artery disease: the OPTIMUS (optimizing antiplatelet therapy in diabetes mellitus)-4 study","volume":"134","author":"Franchi","year":"2016","journal-title":"Circulation"},{"key":"10.1016\/j.vph.2019.106564_bb0155","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.thromres.2016.04.021","article-title":"Diabetes mellitus, glucose control parameters and platelet reactivity in ticagrelor treated patients","volume":"143","author":"Nardin","year":"2016","journal-title":"Thromb. Res."},{"key":"10.1016\/j.vph.2019.106564_bb0160","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1186\/s12933-015-0232-1","article-title":"Diabetes mellitus and platelet reactivity in patients under prasugrel or ticagrelor treatment: an observational study","volume":"14","author":"Alexopoulos","year":"2015","journal-title":"Cardiovasc. Diabetol."},{"issue":"2","key":"10.1016\/j.vph.2019.106564_bb0165","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1007\/s11239-016-1348-1","article-title":"Impact of diabetes on immature platelets fraction and its relationship with platelet reactivity in patients receiving dual antiplatelet therapy","volume":"42","author":"Verdoia","year":"2016","journal-title":"J. Thromb. Thrombolysis"},{"issue":"6","key":"10.1016\/j.vph.2019.106564_bb0170","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1097\/MBC.0b013e328360c75a","article-title":"Sinigaglia F; Novara AtherosclerosisStudy (NAS) group. Mean platelet volume is not associated with platelet reactivity and the extent of coronary artery disease in diabetic patients","volume":"24","author":"De Luca","year":"2013","journal-title":"Blood Coagul. Fibrinolysis"},{"issue":"1","key":"10.1016\/j.vph.2019.106564_bb0175","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1007\/s11239-010-0547-4","article-title":"Lack of correlation between platelet reactivity and glycaemic control in type 2 diabetes mellitus patients treated with aspirin and clopidogrel","volume":"32","author":"Mangiacapra","year":"2011","journal-title":"J. Thromb. Thrombolysis"},{"issue":"2","key":"10.1016\/j.vph.2019.106564_bb0180","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1007\/s11154-017-9424-1","article-title":"The vitamin D deficiency pandemic: approaches for diagnosis,treatment and prevention","volume":"18","author":"Holick","year":"2017","journal-title":"Rev. Endocr. Metab. Disord."},{"issue":"7","key":"10.1016\/j.vph.2019.106564_bb0185","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1111\/eci.12281","article-title":"Vitamin D deficiency is independently associated with the extent of coronary artery disease","volume":"44","author":"Verdoia","year":"2014","journal-title":"Eur. J. Clin. Investig."},{"issue":"2","key":"10.1016\/j.vph.2019.106564_bb0190","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1161\/STROKEAHA.117.019417","article-title":"Tamakoshi a; Japan collaborative cohort study group. relationship between dietary vitamin D and deaths from stroke and coronary heart disease: the Japan collaborative cohort study","volume":"49","author":"Sheerah","year":"2018","journal-title":"Stroke"},{"key":"10.1016\/j.vph.2019.106564_bb0195","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0008670","article-title":"Mitochondrial localization of vitamin D receptor in human platelets and differentiated megakaryocytes","volume":"5","author":"Silvagno","year":"2010","journal-title":"PLoS ONE"},{"key":"10.1016\/j.vph.2019.106564_bb0200","doi-asserted-by":"crossref","first-page":"35798","DOI":"10.1074\/jbc.M404865200","article-title":"Disruption of nuclear vitamin D receptor gene causes enhanced thrombogenicity in mice","volume":"279","author":"Aihara","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.vph.2019.106564_bb0205","doi-asserted-by":"crossref","first-page":"2481","DOI":"10.1021\/pr060600i","article-title":"Relationshipbetweenvitamin D bindingprotein and aspirinresistance in coronaryischemicpatients: a proteomicstudy","volume":"6","author":"L\u00f3pez-Farr\u00e9","year":"2007","journal-title":"J. Proteome Res."},{"issue":"6","key":"10.1016\/j.vph.2019.106564_bb0210","doi-asserted-by":"crossref","first-page":"576","DOI":"10.3109\/09537104.2016.1149159","article-title":"Novara atherosclerosis study group (NAS). vitamin D levels and high-residual platelet reactivity in patients receiving dual antiplatelet therapy with clopidogrel or ticagrelor","volume":"27","author":"Verdoia","year":"2016","journal-title":"Platelets"},{"key":"10.1016\/j.vph.2019.106564_bb0215","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.jjcc.2014.11.006","article-title":"Differential profile in inflammatory and mineral metabolism biomarkers in patients with ischemic heart disease without classical coronary risk factors","volume":"66","author":"Pello","year":"2015","journal-title":"J. Cardiol."},{"key":"10.1016\/j.vph.2019.106564_bb0220","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1111\/jgs.12975","article-title":"Low levels of 25-hydroxy vitamin d and active 1,25-dihydroxyvitamin d independently associated with type 2 diabetes mellitus in older Australian men: the concord health and ageing in men project","volume":"62","author":"Hirani","year":"2014","journal-title":"J. Am. Geriatr. Soc."},{"issue":"5","key":"10.1016\/j.vph.2019.106564_bb0225","doi-asserted-by":"crossref","DOI":"10.1016\/j.ahj.2009.08.013","article-title":"The relation between platelet reactivity and glycemic control in diabetic patients with cardiovascular disease on maintenance aspirin and clopidogrel therapy","volume":"158","author":"Singla","year":"2009","journal-title":"Am. Heart J."},{"issue":"10","key":"10.1016\/j.vph.2019.106564_bb0230","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1136\/hrt.2010.219949","article-title":"Effects of intensive glucose control on platelet reactivity in patients with acute coronary syndromes. results of the CHIPS study (\u201ccontrol de Hiperglucemia y ActividadPlaquetariaenPacientes con SindromeCoronarioAgudo\u201d)","volume":"97","author":"Vivas","year":"2011","journal-title":"Heart"},{"key":"10.1016\/j.vph.2019.106564_bb0235","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1136\/pgmj.70.824.440","article-title":"Improvement in glucose tolerance and beta-cell function in a patient with vitamin D deficiency during treatment with vitamin D","volume":"70","author":"Kumar","year":"1994","journal-title":"Postgrad. Med. J."},{"issue":"4","key":"10.1016\/j.vph.2019.106564_bb0240","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1017\/S0007114509992017","article-title":"Vitamin D supplementation reduces insulin resistance in south Asian women living in New Zealand who are insulin resistant and vitamin D deficient - a randomised, placebo-controlled trial","volume":"103","author":"von Hurst","year":"2010","journal-title":"Br. J. Nutr."},{"key":"10.1016\/j.vph.2019.106564_bb0245","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1309\/AJCPTE3K1SGAPOIZ","article-title":"Assessment of platelet function on whole blood by multiple electrode aggregometry in high-risk patients with coronary artery disease receiving antiplatelet therapy","volume":"131","author":"Paniccia","year":"2009","journal-title":"Am. J. Clin. Pathol."},{"issue":"4","key":"10.1016\/j.vph.2019.106564_bb0250","doi-asserted-by":"crossref","first-page":"409","DOI":"10.2174\/1573399810602040409","article-title":"Platelet resistance to the anti-aggregating agents in the insulin resistant states","volume":"2","author":"Anfossi","year":"2006","journal-title":"Curr. Diabetes Rev."},{"key":"10.1016\/j.vph.2019.106564_bb0255","article-title":"Use of metformin and platelet reactivity in diabetic patients treated with dual antiplatelet therapy","author":"Verdoia","year":"2018","journal-title":"Exp. Clin. Endocrinol. Diabetes"},{"issue":"3","key":"10.1016\/j.vph.2019.106564_bb0260","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/j.thromres.2011.12.002","article-title":"Platelet oxidative stress and thrombosis","volume":"129","author":"Violi","year":"2012","journal-title":"Thromb. Res."},{"key":"10.1016\/j.vph.2019.106564_bb0265","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.thromres.2016.12.019","article-title":"De Luca G; Novara AtherosclerosisStudy group (NAS). Impact of high-dose statins on vitamin D levels and platelet function in patients with coronary artery disease","volume":"150","author":"Verdoia","year":"2017","journal-title":"Thromb. Res."}],"container-title":["Vascular Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1537189119300096?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1537189119300096?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,9,2]],"date-time":"2019-09-02T07:45:00Z","timestamp":1567410300000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1537189119300096"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9]]},"references-count":53,"alternative-id":["S1537189119300096"],"URL":"https:\/\/doi.org\/10.1016\/j.vph.2019.106564","relation":{},"ISSN":["1537-1891"],"issn-type":[{"value":"1537-1891","type":"print"}],"subject":[],"published":{"date-parts":[[2019,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Vitamin D levels and platelet reactivity in diabetic patients receiving dual antiplatelet therapy","name":"articletitle","label":"Article Title"},{"value":"Vascular Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vph.2019.106564","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"106564"}}